Ceros Financial Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Ceros Financial Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$16K	Buy	+178	New	+$15.1K	0.01%	177

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ceros Financial Services's XBI Position: Q1 2019 in Review

Ceros Financial Services opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2019: 178 shares worth $16K. The stake represents 0.01% of the portfolio and ranks #177 among its holdings.

451 funds tracked by Wall St. Rank hold XBI as of Q1 2019.

Ceros Financial Services held 178 shares of State Street SPDR S&P Biotech ETF worth $16K as of Q1 2019.
State Street SPDR S&P Biotech ETF was a new Ceros Financial Services position in Q1 2019.
State Street SPDR S&P Biotech ETF made up 0.01% of Ceros Financial Services's portfolio in Q1 2019, its #177 holding.
451 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2019.

Based on Ceros Financial Services's 13F filing for Q1 2019, filed 3 May 2019.